Zehren brings to Endologix more than twenty years of commercial, sales and marketing, and business development experience in the medical device industry.
Most recently, he served as vice president of sales, Americas at Medtronic Neurovascular and was a senior member of the company's Neurovascular Management Board.
While at Medtronic, he developed and implemented a strategic commercial plan to double revenue in five years.
Prior to that, he spent five years as vice president of Sales at Covidien and ev3. Earlier in his distinguished career, Zehren spent over a decade at Edwards Lifesciences, the last four years of which were in the role of vice president of Sales and Marketing.
Zehren earned his Bachelor of Arts in Biology from College of St. Thomas in Minnesota.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms.
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system
Bonesupport shifts CERAMENT V review to FDA's De Novo pathway
Neola Medical secures US patent for disposable lung monitoring probes
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix